Disadvantages of Novel Oral Anticoagulants Compared with Vitamin K Antagonists

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, talks about the disadvantages of novel oral anticoagulants over vitamin K antagonists.

This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.